Key Takeaways
- Franklin Biotechnology Discovery A (FBDIX) holds a Zacks Mutual Fund Rank of 1 (Strong Buy) and has approximately $1.02 billion in assets.
- FBDIX has reported a 5-year annualized total return of 11.68% and a 3-year return of 29.92%, positioning it well among its peers.
- The fund has higher fees with an expense ratio of 1.01%, and a minimum initial investment requirement of $1,000, despite its strong performance.
Investment Potential
Franklin Biotechnology Discovery A (FBDIX) is a notable option for investors interested in the Sector – Health funds. This fund has a strong reputation, indicated by its Zacks Mutual Fund Rank of 1 (Strong Buy). Healthcare represents a significant portion of the U.S. economy, making mutual funds like FBDIX an appealing investment choice that spans various industries, including pharmaceuticals, medical devices, and healthcare services.
FBDIX, part of the Franklin family of funds from San Mateo, CA, launched in September 1997 and has accumulated assets totaling approximately $1.02 billion. Managed by Evan McCulloch since its inception, the fund’s performance reflects its potential. Over the past five years, it has achieved an annualized total return of 11.68%, while its 3-year return is even more impressive at 29.92%, placing it in the top third in its category.
Investors concerned about volatility should note that FBDIX exhibits a standard deviation of returns—20.81% over the last three years, higher than the category average of 12.4%. Although the fund shows a 5-year beta of 0.58, indicating it is likely to be less volatile than the market, its higher standard deviation suggests increased risk compared to peers.
The fund’s alpha of 3.45 further signifies the fund’s strong performance relative to the S&P 500. This positive alpha indicates that the fund managers are effective at selecting investments that yield returns above the market benchmark.
However, potential investors should consider the fund’s expense ratio of 1.01%, which is above the category average of 0.97%. FBDIX is a load fund, with a minimum initial investment of $1,000, though subsequent investments have no minimum requirement. It is essential for investors to compare costs, especially as competitive pressures in the mutual fund market can affect overall performance.
In summary, while FBDIX has delivered solid returns and holds a strong mutual fund rating, its higher fees and volatility may not appeal to all investors. The fund remains a strong candidate for growth-focused investors interested in the health sector.
The content above is a summary. For more details, see the source article.